aa |
amino acids |
AKT |
Serine-threonine Protein Kinase (now called AKT1) |
AS |
Alternative Splicing |
BC |
Breast Cancer |
CC |
Cervical Cancer |
CD147 |
Cluster of Differentiation 147 |
c/n |
Copy Number |
CRC |
Colorectal Cancer |
CRISPR-Cas9 |
Clustered Regularly-Interspaced Short Palindromic Repeats-CRISPR associated protein 9 |
Dexa |
Dexamethason |
DHT |
Dihydrotestosterone |
E2 |
Estradiol |
EC |
Endometrial Cancer |
ECM |
Extracellular Matrix |
EMT |
Epithelial-Mesenchymal Transition |
ER |
Estrogen Receptor |
ERK1/2 |
Extracellular Signal-regulated Kinase 1/2 |
ESE |
Exonic Splicing Enhancer |
FOX2 |
AS regulator, RNA binding motif protein 9 (RMB9) |
GH |
Growth Hormone |
HCC |
Hepatocellular Carcinoma |
HCV |
Hepatitis C Virus |
H-SIL |
High-grade Squamous Intraepithelial Lesions |
IGF1, 2 |
Insulin-like Growth Factor 1, 2 |
IGF1R/2R |
IGF1 Receptor type I/type II |
INS |
Insulin |
INSR |
INS Receptor |
IHC |
Immunohistochemistry |
IL |
Interleukin |
LC |
Lung Cancer |
L-SIL |
Low-grade Squamous Intraepithelial Lesions |
mIGF1 |
“muscle” specific IGF1 (IGF1Ea isoform) |
MIR-b |
Mammalian Interspersed Repetitive-b Element |
MAPK |
Mitogen-activated Protein Kinase (originally called ERK) |
MGF |
Mechano-growth factor |
MMP-9 |
Matrix Metalloproteinase 9 |
MSCs |
Mesenchymal Stem Cells |
NPY |
Neuropeptide Y |
PC |
Prostate Cancer |
PGE2 |
Prostaglandin E2 |
PI3K |
Phosphatidylinositol 3-Kinase |
PKA, B (AKT), C |
Protein Kinase A, B (AKT), C |
ROS |
Reactive Oxygen Species |
SCID |
Severe Combined Immunodeficiency |
SP1 |
Multiple Specificity Protein 1, a Transcription Factor |
SRSF1 |
Serine-arginine Protein Splicing Factor-2/Alternate Splicing Factor |
TNF-α |
Tumor Necrosis Factor α |
TNM |
T—tumor; N—lymph nodes; M—metastasis |
UTR |
Untranslated Region |
VEGF |
Vascular Endothelial Growth Factor |
wt |
wild type |
ZEB1 |
Zinc Finger E-box-binding Homeobox 1 |